NO133711B - - Google Patents

Download PDF

Info

Publication number
NO133711B
NO133711B NO721191A NO119172A NO133711B NO 133711 B NO133711 B NO 133711B NO 721191 A NO721191 A NO 721191A NO 119172 A NO119172 A NO 119172A NO 133711 B NO133711 B NO 133711B
Authority
NO
Norway
Prior art keywords
ester
formula
acid esters
acid
above meaning
Prior art date
Application number
NO721191A
Other languages
English (en)
Norwegian (no)
Other versions
NO133711C (en, 2012
Inventor
H Meyer
F Bossert
W Vater
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO133711B publication Critical patent/NO133711B/no
Publication of NO133711C publication Critical patent/NO133711C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO1191/72A 1971-04-10 1972-04-07 NO133711C (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2117572A DE2117572C3 (de) 1971-04-10 1971-04-10 Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
NO133711B true NO133711B (en, 2012) 1976-03-08
NO133711C NO133711C (en, 2012) 1976-06-16

Family

ID=5804434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1191/72A NO133711C (en, 2012) 1971-04-10 1972-04-07

Country Status (27)

Country Link
US (1) US3799936A (en, 2012)
JP (1) JPS5527054B1 (en, 2012)
AT (1) AT316552B (en, 2012)
AU (1) AU459338B2 (en, 2012)
BE (1) BE781879A (en, 2012)
BG (4) BG20106A3 (en, 2012)
CA (1) CA925513A (en, 2012)
CH (2) CH571491A5 (en, 2012)
CS (2) CS177846B2 (en, 2012)
DD (1) DD104519A5 (en, 2012)
DE (1) DE2117572C3 (en, 2012)
DK (1) DK132321C (en, 2012)
ES (1) ES401615A1 (en, 2012)
FI (1) FI55187C (en, 2012)
FR (1) FR2132831B1 (en, 2012)
GB (1) GB1331405A (en, 2012)
HU (1) HU165875B (en, 2012)
IE (1) IE36947B1 (en, 2012)
IL (1) IL39170A (en, 2012)
LU (1) LU65129A1 (en, 2012)
NL (1) NL170140C (en, 2012)
NO (1) NO133711C (en, 2012)
PL (2) PL84571B1 (en, 2012)
RO (2) RO63113A (en, 2012)
SE (1) SE371824B (en, 2012)
SU (2) SU475771A3 (en, 2012)
ZA (1) ZA722355B (en, 2012)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920823A (en) * 1972-03-06 1975-11-18 Bayer Ag Use of unsymmetrical esters of n-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid as cardio-vascular agents
US3935223A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3988458A (en) * 1972-03-06 1976-10-26 Bayer Aktiengesellschaft Bicyclic derivatives of 1,4-dihydropyridine 3,5-carboxylic acid esters
US3917619A (en) * 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
US4001258A (en) * 1972-03-06 1977-01-04 Bayer Aktiengesellschaft 2-amino-1,4-dihydropyridine derivatives
US3857849A (en) * 1973-02-28 1974-12-31 Bayer Ag 2-amino-1,4-dihydropyridine derivatives
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3887558A (en) * 1972-03-06 1975-06-03 Bayer Ag Process for producing 2,6-diamino -1,4- dihydro-3,5-pyridine-dicarboxylates and derivatives thereof
US3939171A (en) * 1972-03-06 1976-02-17 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3917620A (en) * 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
US3917622A (en) * 1972-03-06 1975-11-04 Bayer Ag 2-Amino-1,4-dihydropyridine derivatives
DD106832A5 (en, 2012) * 1972-03-06 1974-07-05
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
US3989708A (en) * 1972-08-31 1976-11-02 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
DK152285C (da) * 1975-07-02 1988-10-10 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
JPS6143165A (ja) * 1984-08-07 1986-03-01 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体の製造法
US5571827A (en) * 1990-03-13 1996-11-05 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
AU3128693A (en) * 1991-11-18 1993-06-15 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
ATE234286T1 (de) * 1993-12-10 2003-03-15 Bayer Ag Phenyl-substituierte 1,4-dihydropyridine mit cerebraler aktivität
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE19727350C1 (de) * 1997-06-27 1999-01-21 Bayer Ag Verfahren zur Herstellung von Nifedipin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern

Also Published As

Publication number Publication date
DK132321B (da) 1975-11-24
AU4045472A (en) 1973-10-04
PL84571B1 (en, 2012) 1976-04-30
LU65129A1 (en, 2012) 1972-07-12
NL7204694A (en, 2012) 1972-10-12
NO133711C (en, 2012) 1976-06-16
FI55187B (fi) 1979-02-28
IE36947L (en) 1972-10-10
GB1331405A (en) 1973-09-26
DD104519A5 (en, 2012) 1974-03-12
DK132321C (da) 1976-04-26
ES401615A1 (es) 1975-11-01
BE781879A (fr) 1972-10-10
BG19374A3 (bg) 1975-06-15
DE2117572A1 (de) 1972-10-19
FR2132831B1 (en, 2012) 1975-12-26
IE36947B1 (en) 1977-03-30
ZA722355B (en) 1972-12-27
FR2132831A1 (en, 2012) 1972-11-24
CH571493A5 (en, 2012) 1976-01-15
SE371824B (en, 2012) 1974-12-02
JPS5527054B1 (en, 2012) 1980-07-17
AT316552B (de) 1974-07-25
BG20106A3 (bg) 1975-10-30
RO59959A (en, 2012) 1976-06-15
AU459338B2 (en) 1975-03-05
CS177821B2 (en, 2012) 1977-08-31
FI55187C (fi) 1979-06-11
PL92407B1 (en, 2012) 1977-04-30
RO63113A (fr) 1978-06-15
IL39170A0 (en) 1972-06-28
DE2117572B2 (en, 2012) 1979-06-28
SU475771A3 (ru) 1975-06-30
BG20353A3 (bg) 1975-11-05
CH571491A5 (en, 2012) 1976-01-15
BG19595A3 (en, 2012) 1975-06-25
CS177846B2 (en, 2012) 1977-08-31
CA925513A (en) 1973-05-01
IL39170A (en) 1975-04-25
NL170140B (nl) 1982-05-03
DE2117572C3 (de) 1980-03-20
HU165875B (en, 2012) 1974-12-28
SU431671A3 (en, 2012) 1974-06-05
US3799936A (en) 1974-03-26
NL170140C (nl) 1982-10-01

Similar Documents

Publication Publication Date Title
NO133711B (en, 2012)
JPS6310154B2 (en, 2012)
FI110429B (fi) Menetelmä farmaseuttisten dihydropyridiinien valmistamiseksi
IL29567A (en) History of 4-aryl-1,4-dihydropyridine and their production
JPS58170755A (ja) 新規な１，４−ジヒドロピリジン類
US5258390A (en) 9-(3 cyanophenyl) hexahydro-1,8 acridinedione
Sunkel et al. Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1, 4-dihydropyridines
JPS6217972B2 (en, 2012)
JPS6230780A (ja) １，７−ナフチリジン誘導体及びこれを含有する薬剤
Borzelleca et al. Studies on the respiratory and cardiovascular effects of (-)-cotinine
JP2826379B2 (ja) チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
US5523317A (en) Method of reducing blood pressure
JPS58159489A (ja) ２，３−ジアリ−ル−５−ハロチオフエン化合物
JPS60228485A (ja) テトラヒドロチエノピリジン類
NO814045L (no) Fremgangsmaate til fremstilling av 3,4-bis-substituerte 1,2,5-oksadiazol-2-oksyder
Variava et al. The α‐adrenoceptor blocking effect of indoramin on human isolated smooth muscle
Hoey et al. Cardiovascular effects of clenbuterol are β 2-adrenoceptor-mediated in steers
US4418070A (en) Cardiotonic agents
JPS60233057A (ja) ４‐（ニトロフエニル）‐テトラヒドロピリジン類
JPH01207234A (ja) 虚血性疾患治療剤および心筋保護剤
JP2838282B2 (ja) 血管攣縮治療剤
CA1184562A (fr) Citrate de naftidrofuryl et son application therapeutique
JP3049816B2 (ja) 強心薬
US4738965A (en) 2-oxo-4-(2'-difluoromethylthiophenyl)-5-methoxycarbonyl-6-methyl-1,2,3,4-tetrahydropyrimidine
US5441962A (en) Method for treating hyperlipemia